High Tide sees Q3 revenue C$147M-C$150M

Sees Q3 adjusted EBITDA C$9.6M-C$10.6M. “This quarter’s guidance showcases the strength and momentum of High Tide (HITI) like never before. We expect to deliver record revenue and powerful sequential Adjusted EBITDA growth. These results have been fueled by a projected 7.4% increase in same-store sales during the quarter, which was our fastest growth rate in two years,” said Raj Grover, Founder and Chief Executive Officer of High Tide. “These results, anticipated to be well above analyst expectations, highlight how underappreciated our core Canadian business remains. With our entry into Germany, through the recently announced acquisition of a majority stake in Remexian Pharma GmbH, we’re no longer just a Canadian success story-we’re building the next global cannabis powerhouse.”